English
Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Thyrocare Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Thyrocare Technologies

    Small Cap
    ₹637.3
    +12.8 (2.05%)
    01 July, 2024 06:57 BSE: 539871 NSE: THYROCAREISIN: INE594H01019

    Start SIP in Thyrocare Technologies

    Start SIP

    Thyrocare Technologies Performance

    Day Range

    • Low 625
    • High 645
    ₹ 637

    52 Week Range

    • Low 507
    • High 723
    ₹ 637
    • Open Price625
    • Previous Close625
    • Volume152377

    Thyrocare Technologies Share Price

    • Over 1 Month +3.65%
    • Over 3 Month +8.03%
    • Over 6 Month -0.97%
    • Over 1 Year +22.12%

    Thyrocare Technologies Key Statistics

    P/E Ratio 47.7
    PEG Ratio 4.9
    Market Cap Cr 3,375
    Price to Book Ratio 6.4
    EPS 13.4
    Dividend 0
    Relative Strength Index 52.35
    Money Flow Index 60.73
    MACD Signal 2.23
    Average True Range 19.04
    Thyrocare Technologies Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 141123136124125
    Operating Expenses Qtr Cr 1089210090102
    Operating Profit Qtr Cr 3431373323
    Depreciation Qtr Cr 1011999
    Interest Qtr Cr 11111
    Tax Qtr Cr 66885
    Net Profit Qtr Cr 1915201710
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 531492
    Operating Expenses Annual Cr 390374
    Operating Profit Annual in Cr 134112
    Depreciation Cr 3934
    Interest Annual Cr 42
    Tax Annual Cr 2724
    Net Profit Annual Cr 7157
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 155120
    Cash from Investing Activity Annual Cr -80-32
    Cash from Financing Annual Activity Cr -84-88
    Net Cash Flow Annual Cr 1
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 514521
    Fixed Assets Annual Cr 160157
    Total Non Current Assets Annual Cr 375377
    Total Current Assets Annual Cr 246235
    Total Assets Annual Cr 620612
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 9798
    ROE Annual % 1411
    ROCE Annual % 1915
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2724
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 154135148135136
    Operating Expenses Qtr Cr 120103110101111
    Operating Profit Qtr Cr 3432383425
    Depreciation Qtr Cr 1313111011
    Interest Qtr Cr 11111
    Tax Qtr Cr 65885
    Net Profit Qtr Cr 1815201713
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 581535
    Operating Expenses Annual Cr 434407
    Operating Profit Annual in Cr 137120
    Depreciation Cr 4739
    Interest Annual Cr 42
    Tax Annual Cr 2624
    Net Profit Annual Cr 7164
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 168129
    Cash from Investing Activity Annual Cr -91-39
    Cash from Financing Annual Activity Cr -85-86
    Net Cash Flow Annual Cr 4
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 527534
    Fixed Assets Annual Cr 204195
    Total Non Current Assets Annual Cr 365360
    Total Current Assets Annual Cr 279273
    Total Assets Annual Cr 644633
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 100101
    ROE Annual % 1312
    ROCE Annual % 1816
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2624
    Invest in Thyrocare Technologies

    Thyrocare Technologies Technicals

    EMA & SMA

    Current Price
    ₹637.3
    +12.8 (2.05%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹632.85
    • 50 Day
    • ₹630.88
    • 100 Day
    • ₹625.79
    • 200 Day
    • ₹611.80
    • 20 Day
    • ₹629.56
    • 50 Day
    • ₹632.77
    • 100 Day
    • ₹628.57
    • 200 Day
    • ₹609.22

    Thyrocare Technologies Resistance and Support

    PIVOT
    ₹635.6
    Resistance
    First Resistance 646.70
    Second Resistance 656.10
    Third Resistance 667.20
    RSI 52.35
    MFI 60.73
    MACD Single Line 2.23
    MACD 1.44
    Support
    First Support 626.20
    Second Support 615.10
    Third Supoort 605.70

    Thyrocare Technologies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 160,921 14,568,178 90.53
    Week 58,106 4,528,201 77.93
    1 Month 51,170 3,118,812 60.95
    6 Month 100,495 4,729,285 47.06

    Thyrocare Technologies Result Highlights

    Thyrocare Technologies Synopsis

    NSE-Medical-Services

    Thyrocare Tech. is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 486.46 Cr. and Equity Capital is Rs. 52.93 Cr. for the Year ended 31/03/2023. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.
    Market Cap 3,375
    Sales 524
    Shares in Float 1.54
    No of funds 51
    Yield 2.77
    Book Value 6.57
    U/D Vol ratio 2.5
    LTDebt / Equity 2
    Alpha 0.04
    Beta 0.91

    Thyrocare Technologies Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 71.11%71.11%71.14%71.14%
    Mutual Funds 12.94%12.47%11.91%12.04%
    Insurance Companies 1.08%1.08%1.08%1.08%
    Foreign Portfolio Investors 2.9%3.35%3.46%3.44%
    Financial Institutions/ Banks
    Individual Investors 8.48%9.14%9.66%9.42%
    Others 3.49%2.85%2.75%2.88%

    Thyrocare Technologies Management

    Name Designation
    Mr. Rahul Guha Managing Director & CEO
    Mr. Dharmil Sheth Non Executive Director
    Mr. Hardik Dedhia Non Executive Director
    Mr. Dhaval Shah Non Executive Director
    Mr. Gopalkrishna Shivram Hegde Independent Director
    Dr. Indumati Gopinathan Independent Director
    Dr. Neetin S Desai Independent Director

    Thyrocare Technologies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Thyrocare Technologies Corporate Action

    Date Purpose Remarks
    2024-05-14 Audited Results & Final Dividend
    2024-02-01 Quarterly Results
    2023-10-31 Quarterly Results
    2023-08-01 Quarterly Results
    2023-05-23 Audited Results
    Date Purpose Remarks
    2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
    2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

    Thyrocare Technologies MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 51,566
    Quant Small Cap Fund Growth 21,243
    ICICI Prudential India Opportunities Fund Regular Growth 19,792
    Nippon India Pharma Fund - Growth 7,161
    ICICI Prudential Innovation Fund Regular Growth 5,191

    Thyrocare Technologies FAQs

    What is Share Price of Thyrocare Technologies ?

    Thyrocare Technologies share price is ₹637 As on 01 July, 2024 | 06:43

    What is the Market Cap of Thyrocare Technologies ?

    The Market Cap of Thyrocare Technologies is ₹3374.7 Cr As on 01 July, 2024 | 06:43

    What is the P/E ratio of Thyrocare Technologies ?

    The P/E ratio of Thyrocare Technologies is 47.7 As on 01 July, 2024 | 06:43

    What is the PB ratio of Thyrocare Technologies ?

    The PB ratio of Thyrocare Technologies is 6.4 As on 01 July, 2024 | 06:43

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.